Alzheimer's drug study shows 'tantalizing' results
By: Lauren Gambino
A new drug that destroys the characteristic protein plaques that build up in the brains of Alzheimer's patients is showing 'tantalizing' promise. But experts are cautious as the drug is still in early stages of development.
The study, published in the journal Nature, has shown that the new drug, Aducanumab, is safe to take — and also hinted that it halts memory decline.
In the study of 165 patients over one year— the results showed that the higher the dose of the drug the more effect it had on amyloid plaque buildup in the brain.
Although, along with the higher dosage came side effects such as headaches.
Recruitment for phase 3 of the study is in the works in order to fully test the drug's effect on cognitive decline.
Experts are optimistic about the new drug, calling the new data "tantalizing but not yet definitive," and are eager to see how it performs in larger trials.
RELATED: Common foods suspected of causing cancer: